Valuation: Abbott India Limited

Market Cap 577B 6.02B 5.3B 5.02B 4.53B 8.54B 8.65B 60.06B 23.11B 295B 22.59B 22.1B 946B P/E 2027 *
33.4x
P/E 2028 * 30x
Enterprise Value 553B 5.77B 5.08B 4.81B 4.34B 8.19B 8.29B 57.58B 22.16B 283B 21.66B 21.19B 906B EV / Sales 2027 *
7.37x
EV / Sales 2028 * 6.69x
Free-Float
24.46%
Yield 2027 *
2.49%
Yield 2028 * 2.61%
1 day-0.43%
1 week-0.27%
Current month+5.00%
1 month+3.25%
3 months+7.31%
6 months+3.80%
Current year-6.61%
1 week 26,645.4
Extreme 26645.4
27,845
1 month 25,140.5
Extreme 25140.5
27,845
Current year 25,140.5
Extreme 25140.5
29,250
1 year 25,140.5
Extreme 25140.5
30,598
3 years 21,907.45
Extreme 21907.45
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 52 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Director/Board Member 69 2011-02-28
Chairman 71 2026-08-12
Director/Board Member 61 2019-10-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-0.27%-8.42%+17.23% 6.04B
-1.62%+1.12%+52.54%+116.21% 1,056B
-0.89%-1.37%+43.18%+71.12% 645B
-0.21%-0.73%+13.65%+77.49% 465B
-2.15%-1.34%+74.07%+42.46% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.32%+4.01%+49.67%+58.60% 229B
-1.13%-1.01%+34.99%+102.21% 188B
Average -0.82%+0.13%+32.36%+56.67% 382.18B
Weighted average by Cap. -1.01%+0.30%+40.37%+72.62%

Financials

2027 *2028 *
Net sales 75.05B 783M 689M 653M 590M 1.11B 1.13B 7.81B 3.01B 38.37B 2.94B 2.87B 123B 82.19B 857M 755M 715M 646M 1.22B 1.23B 8.56B 3.29B 42.02B 3.22B 3.15B 135B
Net income 17.25B 180M 158M 150M 136M 255M 259M 1.8B 691M 8.82B 676M 661M 28.27B 19.11B 199M 175M 166M 150M 283M 287M 1.99B 766M 9.77B 748M 732M 31.32B
Net Debt -23.88B -249M -219M -208M -188M -354M -358M -2.49B -957M -12.21B -935M -915M -39.14B -26.98B -281M -248M -235M -212M -400M -405M -2.81B -1.08B -13.79B -1.06B -1.03B -44.23B
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-09-30 ₹27,149.40 -0.43% 319
26-09-29 ₹27,266.65 +1.90% 2,127
26-09-28 ₹26,758.85 -0.66% 429
26-09-25 ₹26,935.80 +0.09% 717
26-09-24 ₹26,911.75 -0.14% 778
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock